Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.
Cell Reports. Medicine
Freeman, Samuel S SS; Sade-Feldman, Moshe M; Kim, Jaegil J; Stewart, Chip C; Gonye, Anna L K ALK; Ravi, Arvind A; Arniella, Monica B MB; Gushterova, Irena I; LaSalle, Thomas J TJ; Blaum, Emily M EM; Yizhak, Keren K; Frederick, Dennie T DT; Sharova, Tatyana T; Leshchiner, Ignaty I; Elagina, Liudmila L; Spiro, Oliver G OG; Livitz, Dimitri D; Rosebrock, Daniel D; Aguet, François F; Carrot-Zhang, Jian J; Ha, Gavin G; Lin, Ziao Z; Chen, Jonathan H JH; Barzily-Rokni, Michal M; Hammond, Marc R MR; Vitzthum von Eckstaedt, Hans C HC; Blackmon, Shauna M SM; Jiao, Yunxin J YJ; Gabriel, Stacey S; Lawrence, Donald P DP; Duncan, Lyn M LM; Stemmer-Rachamimov, Anat O AO; Wargo, Jennifer A JA; Flaherty, Keith T KT; Sullivan, Ryan J RJ; Boland, Genevieve M GM; Meyerson, Matthew M; Getz, Gad G; Hacohen, Nir N